Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Small Cell Lung Cancer Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07195084
What this trial is testing

To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Anhui Provincial Cancer Hospital 12
Early research (Phase 1)WithdrawnNCT03231475
What this trial is testing

Phase I Study of SPH1188-11 in NSCLC

Who this might be right for
NSCLC Stage IIIBNSCLC Stage IV
Shanghai Pharmaceuticals Holding Co., Ltd
Not applicableNot Yet RecruitingNCT07256457
What this trial is testing

Postoperative Pulmonary Function Assessment Based on Deep Learning Study

Who this might be right for
Lung Cancer (NSCLC)
Chinese University of Hong Kong 192
Large-scale testing (Phase 3)WithdrawnNCT04203511
What this trial is testing

INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301)

Who this might be right for
Non-small Cell Lung Cancer
Incyte Corporation
Large-scale testing (Phase 3)Study completedNCT01207011
What this trial is testing

Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Sumitomo Pharma Co., Ltd. 202
Testing effectiveness (Phase 2)Study completedNCT01935336
What this trial is testing

Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers

Who this might be right for
Adenocarcinoma of the LungExtensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung Cancer+5 more
University of Colorado, Denver 171
Early research (Phase 1)Active Not RecruitingNCT04197934
What this trial is testing

WSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases

Who this might be right for
Anaplastic Astrocytoma, IDH-WildtypeGlioblastoma, IDH-WildtypeMetastatic Lung Non-Small Cell Carcinoma+2 more
Mayo Clinic 56
Early research (Phase 1)Not Yet RecruitingNCT07798921
What this trial is testing

JIN-A02 Plus Amivantamab in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI Failure

Who this might be right for
CarcinomaNon-Small-Cell Lung
Yonsei University 36
Testing effectiveness (Phase 2)Study completedNCT02976116
What this trial is testing

A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
NSCLC
Hutchison Medipharma Limited 50
Early research (Phase 1)Ended earlyNCT01565772
What this trial is testing

Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Massachusetts General Hospital 4
Testing effectiveness (Phase 2)Study completedNCT00529100
What this trial is testing

Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 49
Early research (Phase 1)Study completedNCT03810807
What this trial is testing

Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 22
Early research (Phase 1)Study completedNCT01199055
What this trial is testing

CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Daiichi Sankyo Co., Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT00077415
What this trial is testing

3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Cancer Therapeutics Research Group 31
Early research (Phase 1)Not Yet RecruitingNCT06015568
What this trial is testing

Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation

Who this might be right for
Non-Small Cell Lung Cancer、EGFR Sensitive Mutation
Betta Pharmaceuticals Co., Ltd. 172
Early research (Phase 1)Study completedNCT02503358
What this trial is testing

Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Who this might be right for
Stage IIIB Non-Small Cell Lung Cancer AJCC v7Stage IV Non-Small Cell Lung Cancer AJCC v7
OHSU Knight Cancer Institute 23
Large-scale testing (Phase 3)UnknownNCT03856697
What this trial is testing

Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation

Who this might be right for
Advanced Non-small Cell Lung Cancer
Hangzhou ACEA Pharmaceutical Research Co., Ltd. 406
Early research (Phase 1)Study completedNCT01155258
What this trial is testing

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
University of Southern California 19
Testing effectiveness (Phase 2)Ended earlyNCT02949843
What this trial is testing

Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

Who this might be right for
EGFR Activating MutationRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Wake Forest University Health Sciences 19
Early research (Phase 1)Study completedNCT01668823
What this trial is testing

Photodynamic Therapy in Treating Patients With Lung Cancer

Who this might be right for
Adenocarcinoma of the LungLarge Cell Lung CancerRecurrent Non-small Cell Lung Cancer+2 more
Roswell Park Cancer Institute 17
Next Page